HopeStage
Back to all studies
UnknownNCT03781765

Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

Medication studyAges 7–12United StatesADHD
The study in practice

Understand this study

Who could participate?

Listed age limits: 7 years to 12 years.

Listed locations
New YorkSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 4, 2019
Recruitment status
Unknown
Enrollment listed in the registry
44
Sponsor
Icahn School of Medicine at Mount Sinai
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 7 Years to 12 Years
Official registry ID
NCT03781765
Official title
Show the full official title

Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

Recruitment & locations

Status unknown

New York

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Icahn School of Medicine at Mount Sinai, a university.

Does this study involve medication?

Yes. The study involves medication, including Methylphenidate and Atomoxetine.

Who can participate?

Listed age limits: 7 years to 12 years.

Want to explore more studies?

Explore studies